| Product Code: ETC7909772 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Drug-eluting Stents Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Drug-eluting Stents Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Drug-eluting Stents Market - Industry Life Cycle |
3.4 Latvia Drug-eluting Stents Market - Porter's Five Forces |
3.5 Latvia Drug-eluting Stents Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Latvia Drug-eluting Stents Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.7 Latvia Drug-eluting Stents Market Revenues & Volume Share, By Generation, 2021 & 2031F |
3.8 Latvia Drug-eluting Stents Market Revenues & Volume Share, By Scaffold, 2021 & 2031F |
3.9 Latvia Drug-eluting Stents Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 Latvia Drug-eluting Stents Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Latvia Drug-eluting Stents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Latvia |
4.2.2 Technological advancements in drug-eluting stents |
4.2.3 Growing adoption of minimally invasive procedures in healthcare |
4.3 Market Restraints |
4.3.1 Stringent regulations for medical devices in Latvia |
4.3.2 High cost associated with drug-eluting stents |
4.3.3 Limited reimbursement policies for stent procedures |
5 Latvia Drug-eluting Stents Market Trends |
6 Latvia Drug-eluting Stents Market, By Types |
6.1 Latvia Drug-eluting Stents Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Latvia Drug-eluting Stents Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Latvia Drug-eluting Stents Market Revenues & Volume, By Polymer-based, 2021- 2031F |
6.1.4 Latvia Drug-eluting Stents Market Revenues & Volume, By Polymer-free, 2021- 2031F |
6.2 Latvia Drug-eluting Stents Market, By Drug |
6.2.1 Overview and Analysis |
6.2.2 Latvia Drug-eluting Stents Market Revenues & Volume, By Sirolimus, 2021- 2031F |
6.2.3 Latvia Drug-eluting Stents Market Revenues & Volume, By Paclitaxel, 2021- 2031F |
6.2.4 Latvia Drug-eluting Stents Market Revenues & Volume, By Zotarolimus, 2021- 2031F |
6.2.5 Latvia Drug-eluting Stents Market Revenues & Volume, By Everolimus, 2021- 2031F |
6.2.6 Latvia Drug-eluting Stents Market Revenues & Volume, By Biolimus, 2021- 2031F |
6.2.7 Latvia Drug-eluting Stents Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Latvia Drug-eluting Stents Market, By Generation |
6.3.1 Overview and Analysis |
6.3.2 Latvia Drug-eluting Stents Market Revenues & Volume, By 1st Generation, 2021- 2031F |
6.3.3 Latvia Drug-eluting Stents Market Revenues & Volume, By 2nd Generation, 2021- 2031F |
6.3.4 Latvia Drug-eluting Stents Market Revenues & Volume, By 3rd Generation, 2021- 2031F |
6.3.5 Latvia Drug-eluting Stents Market Revenues & Volume, By 4th Generation, 2021- 2031F |
6.4 Latvia Drug-eluting Stents Market, By Scaffold |
6.4.1 Overview and Analysis |
6.4.2 Latvia Drug-eluting Stents Market Revenues & Volume, By Cobalt-Chromium, 2021- 2031F |
6.4.3 Latvia Drug-eluting Stents Market Revenues & Volume, By Platinum-Chromium, 2021- 2031F |
6.4.4 Latvia Drug-eluting Stents Market Revenues & Volume, By Nitinol, 2021- 2031F |
6.4.5 Latvia Drug-eluting Stents Market Revenues & Volume, By Biodegradable, 2021- 2031F |
6.4.6 Latvia Drug-eluting Stents Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Latvia Drug-eluting Stents Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 Latvia Drug-eluting Stents Market Revenues & Volume, By Coronary Diseases, 2021- 2031F |
6.5.3 Latvia Drug-eluting Stents Market Revenues & Volume, By Peripheral Vascular Diseases, 2021- 2031F |
6.6 Latvia Drug-eluting Stents Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Latvia Drug-eluting Stents Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Latvia Drug-eluting Stents Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
7 Latvia Drug-eluting Stents Market Import-Export Trade Statistics |
7.1 Latvia Drug-eluting Stents Market Export to Major Countries |
7.2 Latvia Drug-eluting Stents Market Imports from Major Countries |
8 Latvia Drug-eluting Stents Market Key Performance Indicators |
8.1 Average selling price (ASP) of drug-eluting stents in Latvia |
8.2 Adoption rate of drug-eluting stents in cardiac procedures |
8.3 Number of hospitals offering drug-eluting stent procedures |
8.4 Rate of complications or re-interventions post drug-eluting stent implantation |
8.5 Patient satisfaction and outcomes post drug-eluting stent procedures |
9 Latvia Drug-eluting Stents Market - Opportunity Assessment |
9.1 Latvia Drug-eluting Stents Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Latvia Drug-eluting Stents Market Opportunity Assessment, By Drug, 2021 & 2031F |
9.3 Latvia Drug-eluting Stents Market Opportunity Assessment, By Generation, 2021 & 2031F |
9.4 Latvia Drug-eluting Stents Market Opportunity Assessment, By Scaffold, 2021 & 2031F |
9.5 Latvia Drug-eluting Stents Market Opportunity Assessment, By Application, 2021 & 2031F |
9.6 Latvia Drug-eluting Stents Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Latvia Drug-eluting Stents Market - Competitive Landscape |
10.1 Latvia Drug-eluting Stents Market Revenue Share, By Companies, 2024 |
10.2 Latvia Drug-eluting Stents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here